Workflow
Roche Raises Full-Year Earnings Outlook
WSJ·2025-10-23 05:45

Core Insights - The pharma group has raised its guidance due to strong results achieved so far [1] - There has been an increase in sales when excluding currency fluctuations [1] Summary by Categories - Financial Performance - The company reported a rise in sales excluding currency movements [1] - Future Outlook - The guidance has been lifted, indicating positive expectations for future performance based on current results [1]